ABOUT MEDNAVIGATE
Founded by Dr. Nancy Hedlund, MedNavigate is a limited liability corporation (LLC) which is closely affiliated with a team of independent scientific and strategic healthcare industry advisors standing ready to shine a beacon of light during your product’s journey from discovery through commercialization. Our team works closely with early to mid-cap bio-pharmaceutical and medical device corporations, leveraging respective decades of scientific and leadership experiences, to help your organization to reach your North Star destination.
ABOUT Nancy Hedlund PhD, MBA, RPh
Dr. Nancy Hedlund is the founder and principal consultant for MedNavigate LLC. Her personal mission at MedNavigate is to enable emerging to mid-size life sciences companies to design and execute strategies and tactics which utilize real-world evidence as a complement to clinical trials and/or other predicate proof points. Nancy and her team support each client by acting as scientifically driven and engaged partners on their pathway to success.
Nancy herself is an analytical and strategic advisor who combines thought leadership, extensive life sciences industry experience, and advanced training in observational study design techniques to synthesize data collected from real-world data platforms. Her value based stories and solutions are backed by real-world evidence (RWE).
Health Economics and Real-World Data Consultant
Dr. Hedlund has partnered as an external consultant with companies such as PTC Therapeutics, Prolong Pharmaceuticals, Hollister, Deloitte, Northshore University Health Systems, and several early stage pharmaceutical companies, providing guidance and analytical support to multiple key projects.
Her extensive resume includes industry experience with Syapse, Astellas, Baxter Healthcare Corporation, Hospira (a Pfizer Company) and AmerisourceBergen, in addition to nearly 15 years of institutional clinical experience as a registered pharmacist. She has built out numerous teams, and partnered with medical and marketing leaders across matrix organizations of all sizes to develop and execute RWD-backed evidence strategies and tactics to understand patient care and enable product adoption.
REgulatory Pathways Speaker
A noted speaker, Dr. Hedlund is a frequent guest lecturer at Northwestern University on the topics of ‘Use of Real-World Evidence in Drug Development and Regulatory Submissions’ and ‘Clinical Study Design and Statistical Analysis.’ She is also a member of the American Society of Clinical Oncology (ASCO), the International Society of Pharmaceutical Outcomes Research (ISPOR), Women in BIO (WIB), and the Healthcare Businesswomen’s Association (HBA).
Read Dr. Hedlund’s Selected Publications and Case Studies
invite dr. Hedlund to SPEAK to your organization
Publications
Real-World Use of FLT3-TKIs in R/R FLT3-Mutated AML in the United States. Grinblatt DL, Pandya B, Han W, Sullivan L, Feng Q, Hedlund N. Blood. 2020, vol 136. American Society of Hematology conference abstract (Nov. 5, 2020).
Real-world analysis of prostate-specific antigen (PSA) outcomes among patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA). Stephen J. Freedland, Neil M. Schultz, Anna D. Coutinho, Rupali Fuldeore, Nancy Hedlund, Qi Feng, Krishnan Ramaswamy, and Agnes Hong. Journal of Clinical Oncology. 2020; 38:6 suppl, 33-33.
Drug shortage impacts patient receipt of induction treatment. NG Hedlund, Z Isgor, J Zwanziger, D Rondelli, SY Crawford, DM Hynes, LM Powell. Health services research. 2018; 53 (6), 5078-5105. https://doi.org/10.1111/1475-6773.1302.
Systematic evidence review of rates and burden of harm of intravenous admixture drug preparation errors in healthcare settings. N Hedlund, I Beer, T Hoppe-Tichy, P Trbovich. BMJ open. 2017; 7 (12), e015912.
Primary intravenous set consumption across 3 branded infusion pumps.N Hedlund, S Sarangpur, S Kayler, K O’Brien, I Beer. Journal of Infusion Nursing. 2017; 40 (4), 206.
Hedlund, NG. (2017) Impact of drug shortages on patient treatment and survival: The case of cytarabine and AML leukemia. [Doctoral dissertation, University of Illinois at Chicago, Chicago, IL]. ProQuest Dissertations Publishing.
A systematic review of trends, rates and burden of harm associated with intravenous drug preparation errors in healthcare settings (PS-058). N Hedlund. European Journal of Hospital Pharmacy. 2015; 22 (Suppl 1), A159-A159.
A systematic evidence review of trends, rates, and burden of harm associated with Intravenous drug preparation errors in healthcare settings (PS-058). N Hedlund. Presented at the European Association of Hospital Pharmacists (EAHP) Congress, Hamburg, Germany; 25–27 March 2015.
Dissemination of patient navigation programs across the United States.N Hedlund, BC Risendal, H Pauls, PA Valverde, E Whitley, A Esparza, E Calhoun. Journal of Public Health Management and Practice. 2014; 20 (4), E15-E24.
Evaluating the cost-effectiveness of using boceprevir and telaprevir in the treatment of newly diagnosed Hepatitis C genotype 1 patients: A payer’s perspective. YJ Jalundhwala, P Patel, N Hedlund, W Cheng, B Manzoor, H Patel, D Touchette. Pharmacotherapy. 2012; 32 (10), E300-E301.
The importance of staff diversity to address disparity. Nancy Hedlund, Angelina Esparza, Jerome Yates. Physician executive. 2012; 38 (5), 6
Proceedings of a summit on preventing patient harm and death from iv medication errors Bona Benjamin, Peter B Angood, Frederick Blum, Carolyn M Clancy, Diane D Cousins, Gerald J Dal Pan, Cindy Dusik, Frank Federico, Mary Ann Gibbons, Paul A Gluck, Karl F Gumpper, Lisa Hines, Patricia L Holbrook, Beverly J Holcombe, Henri R Manasse, Donald E Martin, Denise Maxwell-Downing, Virginia R McCann, Kathleen M McCauley, Janet M Nagamine, Richard B Osteen, Jack M Percelay, Jeffrey M Rothschild, Matt Scanlon, Lisa Schulmeister, Rowena N Schwartz, Scott R Smith, Erin Sparnon, Allen J Vaida, Cora Vizcarra, Mary Alexander, Mary Baker, Magda Barini-García, Debra K Bello, Ginny Blocki, Jeffrey Carlisle, Kevin J Colgan, Jeffrey B Cooper, Charles E Daniels, Cheryl Graziano, Peggi Guenter, Nancy Hedlund, Harry Jablonski, Patricia C Kienle, Nancy J Kramer, Ronda K Lehman, Stephen R Lewis, Michelle M Mandrack, James C McAllister, Robert B Meek, William F Minogue, Brent Nibarger, Jeffrey S Nordquist, Shawn O’Connell, Nelson R Patterson, Kelly L Podgorny, Deb R Saine, Kevin A Scheckelhoff, Janet A Silvester, Nathaniel M Sims, Christine Snyder, May Britt Sten, Marc Stranz, John P Straumanis, Dennis K Tribble, Tim Vanderveen, John Vaneeckhout, Billie Whitehurst. American Journal of Health-system Pharmacy. 2011; 65 (24), 2367-2379.
Patents
Systems and methods for a graphical interface including a graphical representation of medical data. JA Hume, R Mayer, DA Lee, G Christensen, C Arvelo, TL Ruchti, TBan, MM Khair, NG Hedlund. US Patent 10,430,761 [2019].
System and method for comparing and utilizing activity information and configuration information from multiple medical device management systems. SI Butler, TM Dunsirn, DE Frede, NG Hedlund, TF Polonus, SJ Pregulman, TJ Ramaker, JE Tillery, MK Van Huis. US Patent 10,242,060 [2019].
System and method for comparing and utilizing activity information and configuration information from multiple medical device management systems.SI Butler, TM Dunsim, DE Frede, NG Hedlund, TF Polonus, SJ Pregulman, TJ Ramaker, JE Tillery, MK Van Huis.US Patent 8,799,012 [2014].
D-U-N-S: 012084470
Vendor Registration: IPG-0485677
CAGE: 94ME9 | Expiration: August 11, 2022